Analyst Reco. Natera, Inc.

Stocks

NTRA

US6323071042

Healthcare Facilities & Services

Market Closed - Nasdaq Other stock markets 21:00:00 10/07/2026 BST			5-day change	1st Jan Change
269.95 ^USD	-4.22%		-3.35%	+17.84%

06-19	Pirche Ag and Natera, Inc. Announce Partnership to Advance Transplant Medicine by Combining Pre-Transplant Risk Stratification and Post-Transplant Dd-Cfdna Monitoring	CI
06-18	Natera Showcases Prospera Test Utility with 21 Presentations At American Transplant Congress	CI

Analyst Reco.

06-12	Natera MRD Leadership Supported by 'Durable' High-Value Market, RBC Says	MT
04-14	William Blair Initiates Natera at Outperform	MT
03-03	Morgan Stanley Cuts Price Target on Natera to $250 From $265, Keeps Overweight Rating	MT
02-27	UBS Adjusts Natera Price Target to $290 From $280, Maintains Buy Rating	MT
01-07	Citigroup Initiates Natera at Buy With $300 Price Target	MT
12-02	Morgan Stanley Raises Price Target on Natera to $265 From $220, Keeps Overweight Rating	MT
11-18	UBS Adjusts Natera Price Target to $280 From $218, Maintains Buy Rating	MT
12/10/25	Natera says to present 14 studies at Esmo, including Imvigor011 oral presentation	RE
03/09/25	RBC Raises Price Target on Natera to $268 From $255, Keeps Outperform Rating	MT
08/08/25	RBC Raises Price Target on Natera to $255 From $251, Keeps Outperform Rating	MT
13/03/25	RBC Initiates Natera at Outperform With $251 Price Target	MT
05/03/25	Morgan Stanley Raises Price Target on Natera to $185 From $176, Keeps Overweight Rating	MT
28/02/25	UBS Raises Price Target on Natera to $211 From $209, Keeps Buy Rating	MT
23/01/25	Barclays Initiates Natera at Overweight	MT
19/11/24	UBS Adjusts Price Target on Natera to $209 From $145, Maintains Buy Rating	MT
13/11/24	Morgan Stanley Adjusts Natera Price Target to $176 From $132, Maintains Overweight Rating	MT
13/08/24	Natera's H2 Guidance Leaves 'Ample Room' for Upside, Morgan Stanley Says	MT
13/08/24	Morgan Stanley Adjusts Natera's PT to $132 From $125, Keeps Overweight Rating	MT
09/08/24	UBS Adjusts Price Target on Natera to $145 From $160, Maintains Buy Rating	MT
09/08/24	UBS Cuts Price Target on Natera to $145 From $160, Maintains Buy Rating	MT
03/06/24	Jefferies Initiates Natera at Buy Rating With $142 Price Target	MT
14/05/24	Piper Sandler Adjusts Price Target on Natera to $120 From $110, Maintains Overweight Rating	MT
13/05/24	BTIG Raises Price Target on Natera to $125 From $100, Maintains Buy Rating	MT
10/05/24	Baird Adjusts Natera Price Target to $117 From $99, Maintains Outperform Rating	MT
10/05/24	UBS Boosts Price Target on Natera to $160 From $104, Keeps Buy Rating	MT